Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Timothy, Juday"'
Autor:
Diana T. Amari, Timothy Juday, Feride H. Frech, Weiying Wang, Zheng Wu, Norman Atkins, Emerson M. Wickwire
Publikováno v:
BMC Geriatrics, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Falls are the leading cause of injury-related death among older Americans. While some research has found that insomnia heightens falls, health care resource utilization (HCRU) and costs, the impact of insomnia treatments on fall r
Externí odkaz:
https://doaj.org/article/ebab02f41da14982bd0386163e35d469
Publikováno v:
CNS Spectrums. 28:265-265
BackgroundTo describe lemborexant and daridorexant for insomnia treatment using number needed to treat (NNT), number needed to harm (NNH), and likelihood to be helped or harmed (LHH).MethodsDichotomous outcomes were identified from the two registrati
Publikováno v:
International Journal of Neuroscience. 131:1058-1065
Insomnia disorder is a prevalent, often unrecognized condition that affects millions. This clinical disorder is characterized by difficulty initiating or maintaining sleep over a sustained period. In fact, insomnia disorder affects much more than sle
Autor:
Sandrine Cure, Florence Bianic, Caroline Espinas, Helene Hardy, Lisa Rosenblatt, Timothy Juday
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0124666 (2015)
Some HIV antiretroviral therapies (ART) have been associated with renal toxicities, which become of increasing concern as HIV-infected patients age and develop comorbidities. The objective of this study was to evaluate the relative impact of atazanav
Externí odkaz:
https://doaj.org/article/24b7a523ca344bbe981b3198fc30e216
Publikováno v:
Journal of Comparative Effectiveness Research. 8:1299-1316
Aim: To compare health plan-paid costs, exacerbations and pneumonia outcomes for patients with chronic obstructive pulmonary disease (COPD) initiating combination tiotropium olodaterol (TIO + OLO) versus triple therapy (TT: long-acting muscarinic ant
Publikováno v:
The Journal of Clinical Psychiatry. 82
Objective: To describe lemborexant for the treatment of insomnia (DSM-5) in adults using number needed to treat (NNT), number needed to harm (NNH), and likelihood to be helped or harmed (LHH). Methods: Lemborexant data were obtained from two Phase 3
Autor:
Derek Misurski, Aurore Duguet, Timothy Juday, Yuri Sanchez Gonzalez, Grégoire Jeanblanc, Olivier Ethgen
Publikováno v:
Journal of Medical Economics. 20:162-170
To estimate the public health impact of comprehensive hepatitis C virus (HCV) screening and access to all-oral, interferon (IFN)-free direct-acting antivirals (DAAs) in the French baby-boomer population (1945-1965 birth cohorts).A sequential, multi-c
Autor:
Patricia Hines, Timothy Juday, Tara Matsuda, Jeff McCombs, Sammy Saab, Yong Yuan, Gilbert L'Italien, Ivy Tonnu-Mihara
Publikováno v:
Universal Journal of Medical Science. 4:10-20
Background and Aims: New Hepatitis C [HCV] drugs are expensive but highly effective but have created an overwhelming ‘cash flow’ problem for payers facing a large bolus of infected patients. Health plans are developing ‘watchful waiting’ stra
Publikováno v:
Journal of the National Medical Association. 112:S34
Autor:
Lisa Rosenblatt, Jennifer N. Sayles, Mark T. Linthicum, Gery Ryan, Sonali P. Kulkarni, David Lowsky, Timothy Juday, Dana P. Goldman, Evan Bloom
Publikováno v:
Health Affairs. 33:410-417
Public health agencies face difficult decisions when allocating scarce resources to control the spread of HIV/AIDS. Decisions are often made with few local empirical data. We demonstrated the use of the robust decision making approach in Los Angeles